We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOAT icon
3601
VanEck Morningstar Wide Moat ETF
MOAT
$12.4B
$27K ﹤0.01%
+365
New +$26.6K
MOD icon
3602
Modine Manufacturing
MOD
$10.5B
$27K ﹤0.01%
1,636
-2,284
-58% -$37.4K
MUFG icon
3603
Mitsubishi UFJ Financial
MUFG
$249B
$27K ﹤0.01%
5,063
-2,901
-36% -$16.1K
MYFW icon
3604
First Western Financial
MYFW
$305M
$27K ﹤0.01%
1,039
+69
+7% +$1.84K
PLAB icon
3605
Photronics
PLAB
$1.95B
$27K ﹤0.01%
2,021
-11,655
-85% -$152K
PLSE icon
3606
Pulse Biosciences
PLSE
$3.17B
$27K ﹤0.01%
1,654
-652
-28% -$12.4K
RC
3607
Ready Capital
RC
$296M
$27K ﹤0.01%
1,714
-8,811
-84% -$130K
RGS icon
3608
Regis Corp
RGS
$68.3M
$27K ﹤0.01%
142
+36
+34% +$7.69K
SABA
3609
Saba Capital Income & Opportunities Fund II
SABA
$222M
$27K ﹤0.01%
2,450
+1,450
+145% +$16K
TH icon
3610
Target Hospitality
TH
$1.66B
$27K ﹤0.01%
7,395
-707
-9% -$2.34K
TNXP icon
3611
Tonix Pharmaceuticals
TNXP
$212M
0
VFF icon
3612
Village Farms International
VFF
$297M
$27K ﹤0.01%
2,606
-914
-26% -$9.62K
VITL icon
3613
Vital Farms
VITL
$496M
$27K ﹤0.01%
1,361
-5,026
-79% -$111K
VNOM icon
3614
Viper Energy
VNOM
$15.4B
$27K ﹤0.01%
1,423
-19,112
-93% -$343K
VRCA icon
3615
Verrica Pharmaceuticals
VRCA
$89.7M
$27K ﹤0.01%
236
-93
-28% -$11.3K
VSS icon
3616
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$27K ﹤0.01%
200
+90
+82% +$12.2K
TECX
3617
Tectonic Therapeutic
TECX
$623M
$27K ﹤0.01%
254
+124
+95% +$14.7K
EVBG
3618
DELISTED
Everbridge, Inc. Common Stock
EVBG
$27K ﹤0.01%
199
-1,477
-88% -$185K
ENG
3619
DELISTED
ENGlobal Corp
ENG
$27K ﹤0.01%
1,115
+925
+487% +$23.2K
PCGU
3620
DELISTED
PG&E Corporation
PCGU
$27K ﹤0.01%
262
+124
+90% +$13.2K
CNCE
3621
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$27K ﹤0.01%
6,300
-4,391
-41% -$18.6K
EMCF
3622
DELISTED
Emclaire Financial Corp
EMCF
$27K ﹤0.01%
876
+207
+31% +$5.8K
SWCH
3623
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$27K ﹤0.01%
1,273
-6,391
-83% -$122K
IEA
3624
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$27K ﹤0.01%
2,139
+1,081
+102% +$13.5K
MILE
3625
DELISTED
Metromile, Inc. Common Stock
MILE
$27K ﹤0.01%
2,907
+1,609
+124% +$14.4K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.